Empower Clinics Inc., - CEO, Steven McAuley
CEO, Steven McAuley
Source: YouTube (Proactive)
  • Empower Clinics (CSE:CBDT) has reported a record number of patient visits at its corporate clinics
  • The company has cited the COVID-19 outbreak as a primary reason for the increase in patient appointments
  • As a medical service provider, Empower’s corporate medical clinics are exempt from certain mandated closures
  • Empower Clinics (CBDT) is up 59.15 per cent to 3 cents per share

Cannabis company Empower Clinics (CSE:CBDT) has reported a record-breaking number of patient visits at its corporate medical clinics. 

The company has cited ongoing COVID-19 impacts as the reason for the unprecedented increase in patient appointments.

As widespread fear sets in over the virus’ toll, Empower visitors have demonstrated a heightened need for CBD medicines.

In addition to experiencing record-pace visits, the company has also made changes to clinic operations and patient management.

In order to effectively weather the COVID-19 storm, Empower has based its changes on recent recommendations from the CDC. The Centers for Disease Control and Prevention has released specific guidance for healthcare facilities, which the company intends to follow.

Empower’s Chairman and CEO, Steven McAuley, commented on the outbreak’s effect on the company and customers. 

“Patients are showing how important their medical cannabis treatment options are to manage increased levels of anxiety, stress, chronic pain, and PTSD.

“We had to quickly adapt clinic operating procedures to ensure optimum safety for employees and patients. We also updated cleaning and sanitation protocols, and provided extensive new communications to our team and patients,” Steven said.

Many US states, including Arizona and Oregon, have declared a State of Emergency, enforcing closures of all non-essential businesses.

However, Empower’s corporate medical clinics are medical service providers, and are therefore considered essential. As a result, the company is not subject to certain mandated closures during the outbreak.

Worldwide, many companies across many industries have seen their share prices plummet due to COVID-19’s impact on the economy.

In contrast, Empower Clinics (CBDT) is up 59.15 per cent to 3 cents per share at 10:38am EST.

More From The Market Online
Cannabis Report image of farmed cannabis plants

The Market Online’s Weekly Cannabis Report – Oct. 4, 2024

Nextleaf announces 12 new cannabis listings across five categories this week, launching between September 2024 and early 2025.
Cannabis Report in text over top a photo of cannabis leaves

The Market Online’s Weekly Cannabis Report – Sept. 27, 2024

Avicanna Inc. (TSX:AVCN) announced a medical cannabis real world evidence study through the MyMedi.ca medical cannabis care platform.
Tilray Brands to launch hemp-derived Delta-9 THC drinks

Tilray unveils new hemp-derived delta-9 THC drink lineup

Tilray Brands (TSX:TLRY) unveils new hemp-derived Delta-9 THC beverages coming to markets across the United States.
Avicanna, MyMedi.ca, The Canadian Pain Society and the Canadian Consortium for the Investigation of Cannabinoids

Avicanna announces medical cannabis study through MyMedi.ca  

Avicanna Inc. (TSX:AVCN) plans a large-scale medical cannabis real world evidence study through the MyMedi.ca medical cannabis care platform.